Dactimicin, a new aminoglycoside: In vitro activity, post-antibiotic effect and interaction with other antibiotics
Tóm tắt
The in vitro activity of the new aminoglycoside dactimicin in comparison to amikacin was tested alone and in combination with piperacillin, mezlocillin and ceftazidime against freshly isolated clinical pathogens. Dactimicin was more active than amikacin againstEnterobacter cloacae, Providencia rettgeri and Salmonella spp., and less active than amikacin againstEscherichia coli, Pseudomonas aeruginosa andAcinetobacter anitratus. Using the checkerboard technique, the combination of either dactimicin or amikacin with the other drugs was shown to result in synergistic interaction against most of the 23 strains tested. Dactimicin-ceftazidime and amikacin-ceftazidime were the most effective combinations, demonstrating synergism against 91 % and 95 % of the isolates respectively. Antagonism was not encountered. Using the time-kill method, synergism was seen in most cases, indifference rarely being seen; antagonism was not observed. Dactimicin induced a post-antibiotic effect which ranged from 1 h forEnterobacter cloacae to 2.4 h forEscherichia coli. An average post-antibiotic effect of 0.6 h was also seen when dactimicin was combined with piperacillin, mezlocillin and ceftazidime. The findings indicate that dactimicin compares favorably in vitro with amikacin and suggest that clinical trials with this drug alone or in combination are warranted.
Tài liệu tham khảo
Price, K. E. Aminoglycoside research 1975–1985: prospects for development of improved agents. Antimicrobial Agents and Chemotherapy 1986, 29: 543–548.
Shomura, T., Kojima, M., Yoshida, J., Ito, M., Amano, S., Totsugawa, K., Niwa, T., Inouye, S., Ito, T., Niida, T. Studies on a new aminoglycoside antibiotic, dactimicin. Producing organism and fermentation. Journal of Antibiotics 1980, 33: 924–930.
Matsuhashi, Y., Yoshida, T., Hara, T., Kazuno, Y., Inouye, S. In vitro and in vivo antibacterial activities of dactimicin, a novel pseudodisaccharide aminoglycoside, compared with those of other aminoglycoside antibiotics. Antimicrobial Agents and Chemotherapy 1985, 27: 589–594.
Craig, W. A., Gudmundsson, G. C. The post-antibiotic effect. In: Lorian, V. (ed.): Antibiotics in laboratory medicine. Williams & Wilkins, Baltimore, 1986, p. 515–536.
Vogelman, B., Gudmundsson, S., Turnidge, J., Leggett, J., Craig, W. A. In vivo postantibiotic effect in a thigh infection in neutropenic mice. Journal of Infectious Diseases 1988, 157: 287–298.
Debbia, E., Varaldo, P. E., Schito, G. C. In vitro activity of imipenem against enterococci and staphylococci: evidence for high rates of synergism with teicoplanin, fosfomycin and rifampin. Antimicrobial Agents and Chemotherapy 1986, 30: 813–815.
Debbia, E., Pesce, A., Schito, G. C. In vitro activity of LY146032 alone and in combination with other antibiotics against gram-positive bacteria. Antimicrobial Agents and Chemotherapy 1988, 32: 279–281.
National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved Standard M7-A. NCCLS, Villanova, PA, 1985.
Pearson, R. D., Steigbigel, R. T., Davis, H. T., Chapman, S. W. Method for reliable determination of minimal lethal antibiotic concentration. Antimicrobial Agents and Chemotherapy 1980, 18: 699–708.
Norden, C. W. Problems in determination of antimicrobial synergism in vitro. Reviews of Infectious Diseases 1982, 4: 276–281.
Humphreys, H., Mulvihill, E. Ciprofloxacin-resistantStaphylococcus aureus. Lancet 1985, ii: 383.
Rubio, T. T., Shapiro, C. Ciprofloxacin in the treatment of pseudomonas infection in cystic fibrosis patients. Journal of Antimicrobial Chemotherapy 1986, 18, Supplement D: 147–152.
Sande, M. A., Scheld, W. M. Combination antibiotic therapy of bacterial endocarditis. Annals of Internal Medicine 1980, 92: 390–395.
Desplaces, N., Gutmann, L., Carlet, J., Guilbert, J., Acar, J. F. The new quinolones and their combination with other agents for therapy of severe infections. Journal of Antimicrobial Chemotherapy 1986, 17, Supplement A: 25–39.
Fuursted, K. Synergistic effect of ampicillin or vancomycin in combination with decreasing concentrations of streptomycin against enterococci. Acta Pathologica, Microbiologica et Immunologica Scandinavica (B) 1988, 96: 395–399.